Magnetar Financial LLC 13D and 13G filings for Adamas Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-10-19 4:26 pm Purchase | 2021-10-11 | 13D | Adamas Pharmaceuticals, Inc. ADMS | Magnetar Financial LLC | 3,131,937 6.850% | 3,131,937 (New Position) | Filing |